Diabetes mellitus and cardiovascular disease

A. M. Wägner, A. Martínez-Rubio, J. Ordóez-Llanos, A. Pérez-Pérez

Producció científica: Contribució a una revistaArticle de revisióRecercaAvaluat per experts

14 Cites (Scopus)


Diabetes is associated with a high incidence and poor prognosis of cardiovascular disease, and with high short- and long-term mortality. Adequate treatment of cardiovascular disorders and aggressive management of coexisting risk factors have proved to be at least as effective in diabetic as in nondiabetic patients in randomized, controlled studies. Indeed, treating diabetic patients with cardiovascular disease results in a larger absolute risk reduction than in nondiabetic subjects. Nevertheless, diabetic patients often receive inadequate therapy, which may, to a certain extent, explain their poor prognosis. Recommendations for the treatment of diabetic patients with acute myocardial infarction should include beta-blockers, aspirin, and ACE-inhibitors in all patients in whom no specific contraindications exist. Fibrinolysis should be administered when indicated, and the benefits of improving glycemic control should not be forgotten either. In patients with multi-vessel disease who need revascularization, when selecting the type of procedure, the superiority of surgical revascularization over angioplasty should be borne in mind. Even heart transplantation should be included as a therapeutic option since there are no data to support the exclusion of patients on account of their diabetes. Finally, coexisting risk factors should be intensively treated through lifestyle intervention, with or without drug therapy, in order to achieve secondary prevention goals. Copyright © 2002 Elsevier Science B.V.
Idioma originalEnglish
Pàgines (de-a)15-30
RevistaEuropean Journal of Internal Medicine
Estat de la publicacióPublicada - 21 de febr. 2002


Navegar pels temes de recerca de 'Diabetes mellitus and cardiovascular disease'. Junts formen un fingerprint únic.

Com citar-ho